Outsourcing-pharma.com has recently reported that the world-renowned Mayo Clinic has shut its doors on clinical services due to increased competition from other companies driving outsourcing of clinical trials to emerging countries such as Latin America, Asia, and Eastern Europe.
Mayo Clinic has mentioned in their statement that they will no longer accept contracts and that 30 employees would lose their job straight away. The statement reads:
“This decision will allow Mayo to focus its efforts on its successful and growing clinical reference laboratory business, Mayo Medical Laboratories, which provides ... laboratory testing services to clients throughout the world.”
Search This Blog
Blog Archive
-
▼
2008
(97)
-
▼
November
(15)
- Clinical Trials Market Expected to Grow in India D...
- Parexel Completes Chinese Bridging Study
- CROs Under Fire
- CRO BioReliance Enters Tech-Development
- India's clinical trials not affected by the recession
- MarketWatch: Quintiles, SAS Announce Development o...
- Biotrial, Full-Service CRO and European Leader in ...
- Economic Crisis Presents an Opportunity for the In...
- Mayo Clinic Pulls Out of Clinical Services
- MarketWatch: EyeGate Pharma Enrolls First Dry Eye ...
- Outsourced Clinical Trials Going Through a Rough P...
- Kendle sees revenue increase
- Nurse dismissed for error in clinical trials
- Nigeria Opens Clinical Trial Center
- India, China, Latin America and CEE as Clinical Tr...
-
▼
November
(15)
No comments:
Post a Comment